Effect of carbazilquinone on lymphoid leukemia L-1210
- PMID: 5476838
Effect of carbazilquinone on lymphoid leukemia L-1210
Similar articles
-
Increased lifespan using the priming dose schedule design in carbazilquinone (NSC-134679) treatment of mouse leukemia L1210.Cancer Chemother Rep. 1972 Feb;56(1):19-23. Cancer Chemother Rep. 1972. PMID: 5030804 No abstract available.
-
Complete inhibition of mouse lymphoid leukemia L-1210 by carbazilquinone.Gan. 1972 Aug;63(4):487-9. Gan. 1972. PMID: 5081624 No abstract available.
-
Effect of 3-[4-amino-2-methyl-5-pyrimidinyl)ethyl[-1(2-chloroethyl)-1-nitrosourea hydrochloride on lymphoid leukemia L-1210.Gan. 1975 Apr;66(2):149-54. Gan. 1975. PMID: 1150007
-
[Current views on drug therapy of tumors].Vopr Onkol. 1970;16(11):108-16. Vopr Onkol. 1970. PMID: 4929044 Review. Russian. No abstract available.
-
[Drug therapy of cervical cancer].Vopr Onkol. 1974;20(8):94-102. Vopr Onkol. 1974. PMID: 4215223 Review. Russian. No abstract available.
Cited by
-
Effects of single chemotherapeutic agents on development of urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in rats.Urol Res. 1987;15(6):329-34. doi: 10.1007/BF00265661. Urol Res. 1987. PMID: 3433593